This week the AACR held a think-tank in Philadelphia on the critical issues in childhood cancer research and care delivery. In attendance were 43 invitees from universities, pharmaceutical companies and patient advocacy groups. Topics included prevention (yes, prevention!), improved care for hereditable cancer predispositions, making drugs available for children with cancer, and the promise of genomics in delivering personalized cancer care. Charles presented on the topic that not only mutation but also cell of origin strongy influences response to treatment - and the types of epigenetic therapies that can be given.
Friday, October 31, 2014
AACR Pediatric Cancer Think-Tank
This week the AACR held a think-tank in Philadelphia on the critical issues in childhood cancer research and care delivery. In attendance were 43 invitees from universities, pharmaceutical companies and patient advocacy groups. Topics included prevention (yes, prevention!), improved care for hereditable cancer predispositions, making drugs available for children with cancer, and the promise of genomics in delivering personalized cancer care. Charles presented on the topic that not only mutation but also cell of origin strongy influences response to treatment - and the types of epigenetic therapies that can be given.
Subscribe to:
Comments (Atom)